- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07541118
Evaluating an Implementation Strategy to Improve Physical Activity and Reduce Cardiovascular Risk Factors in Children
April 17, 2026 updated by: Timothy J Walker, The University of Texas Health Science Center, Houston
The purpose of this study is to evaluate the impact of enhanced Movement for Academic Growth In Classrooms (MAGIC) for improving implementation and effectiveness of physically active breaks, lessons, and motor labs
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
350
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Timothy Walker, PhD
- Phone Number: (713) 500 9664
- Email: Timothy.J.Walker@uth.tmc.edu
Study Contact Backup
- Name: Matthew Lee
- Phone Number: (713) 500-9000
- Email: Matthew.Lee@uth.tmc.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77479
- The University of Texas Health Science Center at Houston
-
Contact:
- Matthew Lee
- Phone Number: (713) 500-9000
- Email: Matthew.Lee@uth.tmc.edu
-
Contact:
- Timothy Walker, PhD
- Phone Number: 713-500-9664
- Email: Timothy.J.Walker@uth.tmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- students enrolled at participating elementary schools at the partner district
- teachers employed at participating elementary schools at the partner district
Exclusion Criteria:
- non English or Spanish speaking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
|
Participants may receive usual support from the district with access to guidance from district leaders
|
|
Experimental: MAGIC
|
The experimental arm includes using a multifaceted implementation strategy to support the use of classroom-based physical activity approaches (e.g., physically active breaks, physically active lessons, and motor labs).
The strategy consists of a series of leadership trainings designed to help them support teachers, teacher trainings to build skills, and a monthly newsletter to reinforce implementation and provide access to existing resources.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Implementation fidelity as assessed by teacher self-reported implementation logs to assess dose of delivery
Time Frame: Baseline
|
Baseline
|
|
Implementation fidelity as assessed by teacher self-reported implementation logs to assess dose of delivery
Time Frame: about 6 months after baseline
|
about 6 months after baseline
|
|
Implementation fidelity as assessed by teacher self-reported implementation logs to assess dose of delivery
Time Frame: about 12 months after baseline
|
about 12 months after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Student Physical Activity as Indicated by Number of Minutes Per Day Spent in Moderate to Vigorous Physical Activity as Assessed by the Actigraph GT3X+ Accelerometer
Time Frame: baseline
|
This outcome measure will be reported as total number of minutes of moderate to vigorous physical activity
|
baseline
|
|
Student Physical Activity as Indicated by Number of Minutes Per Day Spent in Moderate to Vigorous Physical Activity as Assessed by the Actigraph GT3X+ Accelerometer
Time Frame: about 6 months after baseline
|
This outcome measure will be reported as total number of minutes of moderate to vigorous physical activity
|
about 6 months after baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Timothy Walker, PhD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
April 10, 2026
First Submitted That Met QC Criteria
April 17, 2026
First Posted (Actual)
April 21, 2026
Study Record Updates
Last Update Posted (Actual)
April 21, 2026
Last Update Submitted That Met QC Criteria
April 17, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-SPH-25-0498
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Muğla Sıtkı Koçman UniversityEge UniversityCompletedPhysical Activity | Physical Activity Behavior | Physical Activity LevelsTurkey
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
University of ManitobaResearch ManitobaCompletedPhysical Activity | Physical Activity Self-Definition
-
Universidad Pedagogica Nacional, ColombiaEnrolling by invitationPhysical Activity | Running | Running Performance | Running Endurance | Physical Activity in Adults | Physical Activity IntensityColombia
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Universidade do PortoActive, not recruitingPhysical Activity | Physical Fitness | Well BeingPortugal
-
Odense University HospitalUniversity of Southern DenmarkRecruitingQuality of Life | Physical Activity | Physical Disability | Physical Function | ParticipationDenmark
-
Firat UniversityNot yet recruitingUniversity Students | Physical Activity Level | Postural Awareness | Physical Activity AttitudeTurkey
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Pham Ngoc Thach University of MedicineCompletedModerate Physical Activity (MPA) | Vigorous Physical Activity (VPA) | Moderate to Vigorous Physical Activity (MVPA) | Total of Sleep Time (TST)Vietnam
Clinical Trials on MAGIC
-
University of Texas at AustinNational Institutes of Health (NIH)RecruitingInfant Growth | Childhood Obesity Prevention | Parenting BehaviorUnited States
-
Barbara Ann Karmanos Cancer InstituteRecruitingStage I Breast Cancer | Stage II Breast Cancer | Ductal Carcinoma in Situ | Stage III Breast CancerUnited States
-
StereotaxisOsypka AGRecruitingArrhythmias, CardiacPoland, Netherlands, Denmark, Lithuania
-
Stony Brook UniversityUnknown
-
University of MinnesotaCompleted
-
Instituto PalacioseCareYou InnovationCompleted
-
Technical University of MunichCompletedHeart Failure | Sudden Cardiac DeathGermany
-
University of Alabama at BirminghamRecruitingAutism | Pervasive Developmental DisorderUnited States
-
University of Alabama at BirminghamCompleted
-
Yaffa Golan, Ltd.CompletedDiabetes | Peripheral Vascular DiseaseIsrael